Brain Tumor Biomarker Holds Steady at Recurrence, Reshaping Chemo Rechallenge Decisions
A large paired-cohort study finds MGMT promoter methylation remains quantitatively stable in 84 percent of recurrent gliomas, with apparent status ...
A large paired-cohort study finds MGMT promoter methylation remains quantitatively stable in 84 percent of recurrent gliomas, with apparent status ...
A new multi-cohort study identifies the brain protein 14-3-3γ as both a blood-based predictor of postoperative cognitive dysfunction and a ...
A study of 450 colorectal cancer patients shows that POLE and POLD1 proofreading gene mutations predict markedly better immunotherapy response ...
A new single-cell study identifies the transcription factor RBPJ and CD103-positive tissue-resident memory T cells as central drivers of successful ...
Researchers at Sun Yat-sen University developed a nanoscale flow cytometry workflow that counts TRAIL-carrying extracellular vesicles in blood plasma, achieving ...
Researchers have built and validated a four-gene metabolic signature that predicts survival in intrahepatic cholangiocarcinoma more accurately than standard clinical ...
Researchers have introduced the Spatial Immune Barrier Index, a spatial transcriptomics measure that quantifies the suppressive barrier holding immune cells ...
Researchers used a deep learning model to compress 38 senescence-linked blood proteins into a single SASP Score that predicts mortality, ...
A Vietnamese study of 100 young osteosarcoma patients found that a low lymphocyte-to-monocyte ratio measured after chemotherapy independently predicted poorer ...
A transformer-based in-silico gene knockout screen across 109 cell types has identified GSTP1 as a key driver of immunotherapy resistance ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine